Trial · NCT03508440
Intratympanic Steroid for Bell's Palsy
NCT03508440, Phase 2, Phase 3, Completed, University of Missouri-Columbia; results first posted 2024-11-05
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intratympanic Steroid for Bell's Palsy. Trials, record NCT03508440. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03508440
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Intratympanic Steroid for Bell's Palsy
- NCT number
- NCT03508440
- Status
- Completed
- Phases
- Phase 2, Phase 3
- Enrollment
- 10 participants, actual
- Lead sponsor
- University of Missouri-Columbia
- Conditions
- Bell's Palsy, Facial Nerve Paresis
- Interventions
- Intratympanic injection, Prednisone
- First posted
- 2018-04-25
- Last updated
- 2024-11-05
- Results first posted
- 2024-11-05
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Facial Nerve Recovery | Up to 365 days | Time (in days) from the diagnosis or start of treatment to complete recovery of paralysis, defined as house brackman score of 1 |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Facial Nerve Recovery | Up to 365 days | Adults over the age of 18 that presented with Bell's palsy and a House Brackman score of 4 or greater | Days | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Facial Nerve Recovery | Standard of Care | 7 | Standard Deviation 0 | Days | |
| Facial Nerve Recovery | SOC + Injection | 81.56 | Standard Deviation 47.671 | Days |
Source ClinicalTrials.gov
Participant flow9
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Standard of Care | 1 | |
| Overall Study | STARTED | SOC + Injection | 9 | |
| Overall Study | STARTED | Injection Only | 0 | |
| Overall Study | COMPLETED | Standard of Care | 1 | |
| Overall Study | COMPLETED | SOC + Injection | 9 | |
| Overall Study | COMPLETED | Injection Only | 0 | |
| Overall Study | NOT COMPLETED | Standard of Care | 0 | |
| Overall Study | NOT COMPLETED | SOC + Injection | 0 | |
| Overall Study | NOT COMPLETED | Injection Only | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals9
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Standard of Care | 0 | 1 |
| Total, all-cause mortality | SOC + Injection | 0 | 9 |
| Total, all-cause mortality | Injection Only | 0 | 0 |
| Total, other adverse events | Standard of Care | 0 | 1 |
| Total, other adverse events | SOC + Injection | 0 | 9 |
| Total, other adverse events | Injection Only | 0 | 0 |
| Total, serious adverse events | Standard of Care | 0 | 1 |
| Total, serious adverse events | SOC + Injection | 0 | 9 |
| Total, serious adverse events | Injection Only | 0 | 0 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03508440
GET https://conductscience.org/api/trials/v1/NCT03508440/registered